A new flagship Tesco store is set to be built in the heart of Wolverhampton after a preferred company was chosen for the construction contract.

Building firm Bowmer & Kirkland (B&K) will undertake the £60 million development which will provide the Midlands area with a brand new supermarket in the middle of its city centre. The facility will be constructed on the site of Wolverhampton's Royal Hospital after winning its long-running battle with Sainsbury's to claim the flagship spot within the city. It will cover 140,000 sq ft and will see the current buildings remain intact while the main supermarket building is constructed around the hospital, which has been an ever-present within Wolverhampton since 1849.

Officials at the major retailers have said that the plans will also incorporate a host of regeneration projects to help restore the iconic buildings, which have been left to decay over the past few decades. Tesco revealed that it will renovate ten acres of land around the site, which is currently in a derelict state. Proposals for the supermarket have shown that it will become an innovative and unique structure in a bid to restore the old hospital to a state more fitting of its history.

Jonathan Simpson, Tesco corporate affairs manager, told ASAN: "We are absolutely committed to the Royal Hospital scheme. It is of huge strategic importance for Tesco in the region. It's still too early to say exactly when we will start as we’re still putting our development plans together for the next year."

Plans for the development have shown a breakdown of how the space will be used, with the main focus being a 93,000 sq ft anchored major retail store. The rest is set to be comprised of 34,000 sq ft of office and community space while the remaining 9,000 sq ft will consist of smaller retail outlets, a restaurant, café and petrol station. It is designed to provide Wolverhampton with a one-stop shop for all its needs located within easy reach of all parts of the city centre.

Contact us for a security fencing quote.ADNFCR-3337-ID-801418047-ADNFCR